Valeant, Pershing Get Initial OK On $290M Investor Deals
A California federal judge granted preliminary approval Monday to two settlements totaling $290 million from Pershing Square Capital Management LP and Valeant Pharmaceuticals International Inc. to resolve investor claims of an...To view the full article, register now.
Already a subscriber? Click here to view full article